J. Goldman & Co LP - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 140 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,118,500
-25.9%
13,500
-22.3%
0.11%
-33.5%
Q1 2023$4,208,298
+36.9%
17,371
-63.3%
0.17%
+15.6%
Q3 2022$3,074,000
+481.1%
47,300
+944.6%
0.15%
+539.1%
Q1 2018$529,0004,5280.02%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 463,000$99,142,0004.55%
Rock Springs Capital Management LP 342,000$73,232,0002.65%
ACUTA CAPITAL PARTNERS, LLC 33,000$7,066,0002.52%
HealthCor Management, L.P. 262,860$56,286,0001.87%
Baker Brothers Advisors 1,169,278$250,377,0001.65%
EMORY UNIVERSITY 11,391$2,439,0001.60%
PACIFIC VIEW ASSET MANAGEMENT, LLC 8,690$1,862,0001.48%
GREAT POINT PARTNERS LLC 40,400$8,651,0001.35%
SHIKIAR ASSET MANAGEMENT INC 15,341$3,285,0001.28%
ARMISTICE CAPITAL, LLC 80,000$17,130,0001.03%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders